Sharemaestro Newsreel

Multiple Insiders Sold Revvity Shares Presenting Weak Signs For Investors

This article analyzes recent insider selling at Revvity, highlighting transactions by multiple executives and directors. It discusses the volume and value of shares sold, comparing it to the company's market capitalization and past insider activity. The analysis suggests that while not always a definitive …

NEO Stock Price and Chart — NASDAQ:NEO

This article provides a comprehensive overview of NeoGenomics, Inc. (NASDAQ: NEO), including its stock price performance, key financial metrics, recent earnings report, and analyst ratings. It highlights the company's Q2 2026 revenue growth and increased full-year guidance. The article also includes various trading ideas …

Revvity (RVTY) To Report Earnings Tomorrow: Here Is What To Expect

Revvity (NYSE:RVTY) is set to report earnings tomorrow, with analysts expecting a 3.9% year-on-year revenue growth after the company missed expectations last quarter. The market anticipates the business will stay on course, as peer companies like Avantor and Thermo Fisher have already reported positive …

ILLUMINA INC : PIPER SANDLER RAISES TARGET PRICE TO $225 FROM $200

Piper Sandler has increased its target price for Illumina Inc. (ILMN.O) to $225, up from the previous target of $200. This adjustment reflects the analyst's updated outlook on the company. The article notes that the content reflects the author's opinion and is not investment …

ICON Announces Results of Annual General Meeting 2026

ICON plc announced that all resolutions presented at its Annual General Meeting (AGM) held on July 31, 2026, were passed by shareholders. The announcement includes a detailed breakdown of the voting results for each resolution, covering the re-election and election of board members, review …

Philippine Consulate Attends Biotech and Beyond Speaker Series Featuring Thermo Fisher Scientific

Consul Rowena Pangilinan-Daquipil and Economic Assistant Danica Vismonte represented the Philippine Consulate General in San Francisco at the "Biotech and Beyond Speaker Series" featuring Thermo Fisher Scientific. The event highlighted Thermo Fisher's forensic DNA technologies and facilitated discussions on potential collaborations with Philippine law …

ETFs Investing in Revvity, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Revvity, Inc., a company in the medical specialties sector. The ETFs are sorted by their market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, change …

Precipio Schedules Q2 2026 Shareholder Update Call

Precipio (PRPO) announced it will host its Q2 2026 shareholder update call on August 17, 2026, at 5:00 p.m. ET to discuss performance in its cancer diagnostics businesses. CEO Ilan Danieli will provide remarks on progress and engage in a live Q&A session. TipRanks' …

An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know

An IQVIA executive, Keriann Cherofsky, sold 558 shares worth approximately $136,827 on July 29, 2026, just before the stock slipped. Despite the sale, Cherofsky retains a significant direct holding of 2,989 shares valued at over $739,000, indicating this was likely routine portfolio management rather …

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings Inc. CEO Ari Bousbib sold approximately 106,000 shares for $26.1 million by exercising expiring stock appreciation rights. This transaction is considered calendar management rather than a reflection of his outlook on the company, as he retained a significant beneficial ownership of 1.4 …

Why IQVIA Holdings (IQV) Is Up 13.0% After Raising 2026 Revenue Outlook And Extending Buybacks

IQVIA Holdings (IQV) saw its stock rise by 13.0% after announcing strong second-quarter 2026 results, including increased revenue and a raised full-year 2026 revenue outlook. The company also extended its share repurchase program, signaling management's confidence in its AI-enabled growth strategy. Despite positive revenue …

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased securities between April 16, 2025, and May 4, 2026. The lawsuit alleges that GeneDx made materially false and misleading statements regarding …

Natera Inc Lobbyists, 2023

This OpenSecrets.org page details Natera Inc.'s lobbying activities for 2023. It lists four lobbyists—Meagan Daly, Brandon Kirby, Ethan Mahler, and Oliver Meissner—all from Consilio Group, who worked on behalf of Natera Inc. The report indicates Natera Inc. had no "revolving door" lobbyists (former federal …

Precision Trading with Sotera Health Company (SHC) Risk Zones

This article provides a detailed analysis of Sotera Health Company (SHC) using AI models to suggest precision trading strategies. It highlights a strong near-term sentiment for SHC, a mid-channel oscillation pattern, and an exceptional risk-reward short setup. The analysis includes institutional trading strategies tailored …

MYGN Slides As Myriad Genetics Slashes 2026 Revenue Outlook

Myriad Genetics Inc. (MYGN) stock slid by 45.72% after the company slashed its 2026 revenue outlook to $770M-$790M from a prior $860M-$880M, falling short of Street expectations. This reduction was attributed to competitive genetic testing advancements, weaker Q2 performance, and increased payer friction, leading …

Adaptive Biotechnologies (ADPT) Raised MRD Guidance, Is The Stock Fairly Valued?

Natera (NTRA) Sets Earnings Date, Is The Stock Fully Priced?

Royal Bank of Canada Sells 2,247 Shares of Mettler-Toledo International, Inc. $MTD

Royal Bank of Canada reduced its stake in Mettler-Toledo International (NYSE:MTD) by selling 2,247 shares, though it still holds 46,420 shares valued at $58.5 million. The company recently exceeded quarterly earnings expectations, reporting an adjusted EPS of $11.46 against a $10.80 consensus, with revenue …

RadNet (RDNT) Projected to Announce Quarterly Earnings on Sunday

The Technical Signals Behind (RVTY) That Institutions Follow

Revvity Inc. (NASDAQ: RVTY) is showing a neutral sentiment across all time horizons, indicating a wait-and-see approach for institutional investors. The article highlights a high-risk reward short setup with a 10.5% downside target versus 0.3% risk. AI-generated trading strategies are provided, including position trading, …

IBO|Impact Biomedical Inc|Price:0.430|

This article provides a comprehensive stock analysis of Impact Biomedical Inc (IBO) by TradingKey, assigning it a stock score of 3.94/10. It highlights that the company's fundamentals are stable with high growth potential, yet its valuation is considered fairly valued within the Biotechnology & …

Freenome Holdings Number of Employees 2026 | Employee Count & Headcount Data

Freenome Holdings, a Biotech and Healthcare Services company founded in 2014 and headquartered in Brisbane, California, had approximately 527 employees worldwide as of March 2026. This represents a 26.8% decline from 719 employees in 2023, though the company saw a slight increase from a …

Should Twist Bioscience’s US$17.05 Million Class Action Settlement Reshape Risk Perceptions for TWST Investors?

Twist Bioscience (TWST) recently held a hearing for a proposed US$17.05 million cash settlement to resolve a securities class action lawsuit. This settlement, if approved, would address past legal risks related to capital-raising activities for the period between December 2018 and November 2022. While …

Renaissance Technologies LLC Acquires Shares of 8,350 Mettler-Toledo International, Inc. $MTD

Renaissance Technologies LLC has acquired 8,350 shares of Mettler-Toledo International, Inc. (NYSE:MTD) valued at approximately $10,531,000 during the first quarter. Other institutional investors also adjusted their positions in MTD. The company recently reported strong quarterly earnings, exceeding expectations, and raised its full-year outlook, while …

Danaher Corp. (1DHR) Q2 2026 Earnings Report - Results, Call & Slides

Danaher Corporation (1DHR) reported strong Q2 2026 earnings, beating analyst expectations for both EPS and revenue. The company saw accelerating core growth, robust cash generation, and raised its full-year EPS guidance despite headwinds from bioprocessing shipment timing and respiratory-related issues. Strategic M&A and share …

Labcorp Holdings Number of Employees 2026 | Employee Count & Headcount Data

This article provides an in-depth analysis of Labcorp Holdings' workforce as of March 2026, using data from Revelio Labs. It details the company's global employee count, which is approximately 71,180, and notes a 4.0% decline since 2023. The report also covers hiring trends, geographic …

CareDx (CDNA) Following Raised Guidance And Profit Swing, Does The Stock Look Fully Valued

The Technical Signals Behind (RDNT) That Institutions Follow

This article analyzes the technical signals for Radnet Inc. (NASDAQ: RDNT), highlighting strong near-term sentiment that could challenge persistent mid and long-term weakness. It identifies a mid-channel oscillation pattern and an exceptional risk-reward short setup. The piece also details AI-generated institutional trading strategies for …

Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Mettler-Toledo (MTD) Is Up 6.7% After Raising 2026 Outlook And Announcing $875 Million Buyback

Natera (NTRA) Stock Trades At A Premium To Sales After A 425% Return

Can Illumina (ILMN) Hold Its Price As Cash Flow And Earnings Clash?

Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Guidance and Q3 Outlook

Qiagen N.V. $QGEN Shares Sold by Edgestream Partners L.P.

CFO Awards honoree Frank Stokes of Castle Biosciences Inc.

Frank Stokes of Castle Biosciences Inc. has been recognized as an honoree for the Houston Business Journal's 2026 CFO Awards. The article highlights Stokes as one of several distinguished individuals acknowledged for their financial leadership. Other honorees include Frank Wilson IV, Ebru Akyildiz, Stephanie …

The Bull Case For Labcorp (LH) Could Change Following Guidance Hike And New Genetic Panel Launch

Labcorp Holdings Inc. reported strong Q2 and first-half results, raising its 2026 revenue growth guidance to 5.4%–6.3%, and completed a significant share repurchase program. The company also launched its new Marker by Labcorp Genetic Health Panel, a direct-to-consumer genetic testing service, which is expected …